Persistence of the immune response induced by BCG vaccination
作者： Rosemary E Weir , Patricia Gorak-Stolinska , Sian Floyd , Maeve K Lalor , Sally Stenson
关键词:
摘要: Background Although BCG vaccination is recommended in most countries of the world, little known persistence BCG-induced immune responses. As novel TB vaccines may be given to boost immunity induced by neonatal vaccination, evidence concerning vaccine-induced response would help inform decisions about when such boosting effective.
biomedcentral.com
springer.com
doaj.org
lshtm.ac.uk参考文章(21)
B Genser, C Santa'Ana, M Yury Ichihara, I Dourado, SC de Brito, ML Barreto, LC Rodrigues, SM Pereira, SS Cunha, MA Hijjar, A Cruz, Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil. International Journal of Tuberculosis and Lung Disease. ,vol. 9, pp. 1171- 1173 ,(2005)
I. N. Guedes, L. C. Rodrigues, J. A. C. Sterne, Does the efficacy of BCG decline with time since vaccination International Journal of Tuberculosis and Lung Disease. ,vol. 2, pp. 200- 207 ,(1998)
H Igari, A Watanabe, T Sato, Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection. International Journal of Tuberculosis and Lung Disease. ,vol. 11, pp. 788- 791 ,(2007)
Karen Noakes, Mary Ramsay, David Salisbury, Immunisation against infectious disease TSO. ,(2006)
Harvey V. Fineberg, Frederick Mosteller, Catherine S. Berkey, Graham A. Colditz, Elisabeth Burdick, Mary E. Wilson, Timothy F. Brewer, The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis : meta-analyses of the published literature Pediatrics. ,vol. 96, pp. 29- 35 ,(1995)
Peter Andersen, T. Mark Doherty, The success and failure of BCG - implications for a novel tuberculosis vaccine. Nature Reviews Microbiology. ,vol. 3, pp. 656- 662 ,(2005) , 10.1038/NRMICRO1211
Helen McShane, Ansar A Pathan, Clare R Sander, Sheila M Keating, Sarah C Gilbert, Kris Huygen, Helen A Fletcher, Adrian V S Hill, Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nature Medicine. ,vol. 10, pp. 1240- 1244 ,(2004) , 10.1038/NM1128
R. E. WEIR, P. E. M. FINE, B. NAZARETH, S. FLOYD, G. F. BLACK, E. KING, C. STANLEY, L. BLISS, K. BRANSON, H. M. DOCKRELL, Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clinical and Experimental Immunology. ,vol. 134, pp. 285- 294 ,(2003) , 10.1046/J.1365-2249.2003.02272
Andrea R Bennett, Patricia Gorak-Stolinska, Anne Ben-Smith, Sian Floyd, Catherine M De Lara, Rosemary E Weir, Maeve K Lalor, Kandakuone Makamo, Glyn K Msiska, Amelia C Crampin, Paul EM Fine, Hazel M Dockrell, Peter CL Beverley, The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: A new repertoire evolves over 12 months Vaccine. ,vol. 24, pp. 2617- 2626 ,(2006) , 10.1016/J.VACCINE.2005.12.011
Ian Sutherland, V.H. Springett, Effectiveness of BCG vaccination in england and wales in 1983 Tubercle. ,vol. 68, pp. 81- 92 ,(1987) , 10.1016/0041-3879(87)90023-7